Literature DB >> 8580833

True histiocytic lymphoma: a study of 12 cases based on current definition.

O W Kamel1, C D Gocke, D L Kell, M L Cleary, R A Warnke.   

Abstract

True histiocytic lymphoma (THL), as it is currently defined, is a rare entity. We report 12 cases of THL seen at Stanford over the last ten years. By definition, the neoplastic cells in each case showed histological and immunological evidence of histiocytic differentiation. Seven females and five males ranged in age from 9 to 67 years. Sites of involvement included lymph node, soft tissue, bone, stomach, small intestine, mediastinum, kidney, breast and salivary gland. Lymph nodes showed diffuse architectural effacement and/or a paracortical pattern of involvement. The infiltrates involved other tissues in a diffuse pattern. Cytologically the cells were characterized by abundant eosinophilic cytoplasm and enlarged, indented eccentrically placed nuclei containing prominent nucleoli. In all cases the cytological features were sufficiently atypical to indicate a neoplastic infiltrate. Paraffin section immunophenotyping demonstrated reactivity of the atypical cells for CD15, 43, 45RO, 45RB, 68, lysozyme and/or S100. In frozen sections, the atypical cells demonstrated reactivity for CD4 (cytoplasmic), 11c, 14, 15, and/or 68. Genotypic studies were performed on 3 cases, one of which showed rearrangements of immunoglobulin heavy and light chain genes. Follow-up was available on eleven patients, six of whom died of disease 0.5 to 36 months following diagnosis.

Entities:  

Mesh:

Year:  1995        PMID: 8580833     DOI: 10.3109/10428199509064926

Source DB:  PubMed          Journal:  Leuk Lymphoma        ISSN: 1026-8022


  2 in total

1.  A case of histiocytic sarcoma presenting with primary bone marrow involvement.

Authors:  Byeong Seok Sohn; Tark Kim; Jeong Eun Kim; Eunsin Bae; Chan-Jeoung Park; Jooryung Huh; Sang-Oh Lee
Journal:  J Korean Med Sci       Date:  2010-01-19       Impact factor: 2.153

2.  A case of primary histiocytic sarcoma arising from thyroid gland.

Authors:  Lu Yu; Shou Jing Yang
Journal:  Pathol Oncol Res       Date:  2009-08-05       Impact factor: 3.201

  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.